CAMBRIDGE, MA -— GenoSpace, a precision medicine software company

that has developed a comprehensive suite of tools to enable the broad use of genomic, imaging

and other biomedical data in research and clinical care, today announced the appointment of

Michelle Munson, CEO of Aspera, an IBM Company, to its board as an independent director.

“We are pleased to welcome Michelle to the leadership team at GenoSpace,” said John

Quackenbush, Chairman of the Board of GenoSpace. “We have had a strong relationship with

Michelle’s team at Aspera beginning with some of our earliest customer deployments, and we

welcome her depth of experience and clear enthusiasm for applying advanced technical

solutions to solving complex problems.”

“GenoSpace is a highly talented and promising team that is focused on fundamentally

advancing medicine through innovation at the intersection of genomic science and computing,

an area in which I have had significant exposure through Aspera, and which means a great deal

to me as a computer scientist. I am honored to help contribute my experience in creating and

growing a technology start-up to this exceptional group,” said Munson.

Ms. Munson is Chief Executive Officer and co-founder of Aspera, which was acquired by IBM in

January 2014. She is co-inventor, along with Serban Simu, of Aspera’s Emmy Award–winning

FASP™ transport technology for high-performance bulk data transfer. Before she founded

Aspera in 2004, Ms. Munson was a software engineer at research and start-up companies

specializing in content networking and distributed systems. She holds dual B.Sc. degrees in

electrical engineering and physics from Kansas State University and was a Goldwater Scholar

for achievement in science and mathematics, as well as a Fulbright Scholar at Cambridge

University, where she received a postgraduate diploma in computer science. In 2006, Ms.

Munson became the youngest-ever KSU College of Engineering Alumni Fellow.

About GenoSpace

At GenoSpace, we are Digital Architects of Genomic Medicine™. GenoSpace has built a

comprehensive platform for precision medicine to enable interpretation, analysis, reporting and

collaboration on high-dimensional genomic and other biomedical data. With specific applications

supporting research, development, pathology and clinical care, many of the most advanced

precision medicine organizations are powered by GenoSpace. Please visit

www.genospace.com for more information.